冠状动脉疾病中的阿波利波蛋白A-I输液:系统性审查
Rimsha Ahmad1, Syed Sadam Hussain1, Saifullah Khan2
1From the Department of Internal Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Cardiology in review
|July 17, 2025
概括
脂蛋白A-1 (apoA-1) 输液通过改善HDL功能和胆固醇清除,显示出治疗冠状动脉疾病 (CAD) 的前景. 这种方法针对HDL功能,而不仅仅是胆固醇水平,以减少心血管事件.
科学领域:
- 心血管医学 心血管医学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉疾病 (CAD) 仍然是全球主要的死亡原因.
- 高密度脂蛋白 (HDL) 胆固醇升高疗法没有持续减少心血管事件.
- 焦点正在转向HDL功能,特别是胆固醇排泄能力 (CEC).
研究的目的:
- 审查使用阿波利波蛋白A-1 (apoA-1) 输注的理由.
- 总结一下CAD中apoA-1输注的临床试验环境.
- 探索apoA-1作为CAD的新型治疗点.
主要方法:
- 对apoA-1的抗动原作用进行的临床前研究的综述.
- 对涉及apoA-1输注的早期人体试验的分析.
- 检查apoA-1在逆胆固醇运输和CEC中的作用.
主要成果:
- 在临床前的模型中,ApoA-1输注显示出抗动脉增生效应.
- 早期的人体试验表明,apoA-1输液可以增强CEC和胆固醇清除.
- ApoA-1输液可能提供一种新的策略,不仅仅是提高HDL-C水平.
结论:
- ApoA-1输液代表了对CAD的有前途的治疗策略.
- 通过apoA-1准HDL功能是心血管研究的一个关键领域.
- 进一步的临床试验正在评估apoA-1输液用于CAD预防和治疗.
相关概念视频
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Acute Coronary Syndrome III: Diagnostic Studies
25
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
Coronary Artery Disease V: Interprofessional Care
37
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
37
Coronary Artery Disease I: Introduction
60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60
Coronary Artery Disease IV: Preventive Measures
38
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
38
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K


